Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Multiple Myeloma × Aprepitant × Clear all

Phase

Phase NA 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 9 Nausea 5 Breast Neoplasms 4 Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Dexamethasone 136 Bortezomib 77 Lenalidomide 74 Thalidomide 39 Melphalan 36 daratumumab 35 pomalidomide 30 Cyclophosphamide 29 Calcium Dobesilate 23 carfilzomib 20 Prednisone 18 Doxorubicin 13 elotuzumab 11 Filgrastim 11 ixazomib 10 isatuximab 9 Vincristine 9 belantamab mafodotin 8 Zoledronic Acid 8 Peripheral Blood Stem Cell Transplantation 8 dexamethasone acetate 7 Granulocyte Colony-Stimulating Factor 7 Epoetin Alfa 6 selinexor 5 Carmustine 5 fludarabine 4 Radiotherapy 4 Interferon-alpha 4 Etoposide 4 Cytarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00571168 2010-01-12

EmNa

Heidelberg University

Phase 3 Unknown

Multiple Myeloma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡